Aarti Drugs Limited has announced the launch of the Second 100 Days Campaign – "Saksham Niveshak" following a directive from the Investor Education and Protection Fund Authority (IEPFA) under the Ministry of Corporate Affairs (MCA). The campaign, running from April 1, 2026 to July 9, 2026, aims to help shareholders claim unpaid or unclaimed dividends and update their KYC details. The company has now published newspaper advertisements and notified stock exchanges under regulatory compliance requirements.

Regulatory Compliance and Publication Details

Aarti Drugs Limited has fulfilled its regulatory obligations by notifying both BSE Limited and National Stock Exchange of India Limited about the newspaper publication of the campaign notice. The company submitted its compliance letter dated April 7, 2026, under reference ADL/SE/2026-27/03, in accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Campaign Overview and Purpose

The IEPFA, through its communication dated March 27, 2026, has requested companies to relaunch this initiative to reach out to shareholders whose dividends remain unpaid or unclaimed. The primary objective is to create awareness among shareholders to update their KYC-related details and claim any outstanding dividends before they get transferred to the Investor Education and Protection Fund (IEPF).

Required Documentation and Submission Process

Shareholders need to submit specific forms and documents to claim their unpaid dividends and update their information:

Submission Channels and Contact Information

Shareholders can submit their documents through multiple channels to MUFG Intime India Private Limited, the company's Registrar & Share Transfer Agent:

Important Guidelines and IEPF Transfer

Shareholders must update essential information including PAN details, nomination details, contact information, bank account details, and specimen signatures. Since dividends are payable only through electronic mode, amounts will be credited to shareholders' bank accounts only after required information is updated. The company emphasizes that dividend amounts not claimed for seven consecutive years will result in transfer of corresponding equity shares to the IEPF Authority.

The campaign notice is available on the company's website and stock exchange websites. Shareholders are encouraged to submit their documents by July 9, 2026 to ensure successful claim of unpaid dividends and prevent share transfer to IEPFA.

Aarti Drugs Limited has submitted its quarterly compliance certificate to stock exchanges, fulfilling regulatory requirements under SEBI Regulation 74(5) for the quarter ended March 31, 2026. The pharmaceutical company filed the mandatory certificate on April 6, 2026, with both BSE and National Stock Exchange of India Limited.

Regulatory Compliance Certificate

The certificate was issued by MUFG Intime India Private Limited (formerly Link Intime India Private Limited), which serves as the registrar and transfer agent for Aarti Drugs Limited. The document confirms compliance with Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018.

Certificate Confirmation

MUFG Intime India Private Limited confirmed that all securities received from depository participants for dematerialisation during the quarter were properly processed. The registrar verified that:

• Securities received for dematerialisation were confirmed or rejected to depositories within prescribed timelines
• All security certificates were mutilated and cancelled after due verification
• Depository names were substituted in the register of members as registered owners
• Securities comprised in certificates have been listed on stock exchanges where earlier issued securities are listed

Corporate Information

Aarti Drugs Limited operates as a manufacturer of bulk drugs and chemicals. The company's corporate office is located at Mahendra Industrial Estate, Sion (East), Mumbai, while its registered office is situated at MIDC Tarapur, Village Pamtermbhi, District Palghar, Thane.

The certificate was signed by Rushikesh Deole, Company Secretary and Compliance Officer, and Ashok Shetty, Sr. Vice President-Corporate Registry at MUFG Intime India Private Limited. This filing represents routine regulatory compliance, ensuring transparency in the company's dematerialisation processes and adherence to SEBI guidelines for depositories and participants.